Traditional Chinese medicine compound for treating sicca syndrome and application thereof

Abstract

The invention discloses a traditional Chinese medicine for treating sicca syndrome and application thereof. The traditional Chinese medicine is prepared from the following components in parts by weight: gypsum, rhizoma anemarrhenae, rhizoma phragmitis, square-stem, folium mori, chrysanthemum, astragalus membranaceus, radix glehniae, radix ophiopogonis, radix rehmanniae, radix puerariae and radix achyranthis bidentatae. The traditional Chinese medicine for treating the sicca syndrome, disclosed by the invention, has the functions of clearing heat of stomach, soothing liver, removing heat and retaining body fluid. The traditional Chinese medicine disclosed by the invention has unique advantages, has the immunologic functions of obviously improving symptoms of thirst and dry eye syndrome of the sicca syndrome and improving dysfunction, is better than an immunosuppressor in treatment effect, and is free of such side effects of the immunosuppressor as inducing hepatic and renal function lesion and causing myelosuppression, so the traditional Chinese medicine is a safe and effective clinical pure traditional Chinese medicine preparation and can be used for preparing a medicament for treating the sicca syndrome.

Description

technical field [0001] The invention relates to a compound traditional Chinese medicine for treating rheumatic diseases, in particular to a traditional Chinese medicine composition for treating Sjögren's syndrome. Background technique [0002] Sjogren's syndrome is an autoimmune disease of unknown etiology characterized by high lymphocyte infiltration of exocrine glands. It mainly invades the lacrimal gland and salivary gland, and the main clinical manifestation is dry mouth and eyes, and it may also be accompanied by extraglandular symptoms, such as arthritis, myalgia, rash, rampant dental caries and other symptoms. The prevalence rate of this disease in our country is 0.3% to 0.7%, and its incidence rate ranks second among rheumatic immune diseases. However, there is no specific drug on the market at present, and most of them use symptomatic treatment or immunosuppressant, but due to reasons such as uncertain curative effect, or high toxicity and side effects, the phenome...

AI Technical Summary

Problems solved by technology

[0004] In the prior art, the Chinese patent database discloses several compound Chinese medicines for treating Sjogren's syndrome (such as CN101804174B, CN102813832B, CN102526596A, CN102772671A, CN103055034A, etc.), and the medicines disclosed in the above-mentioned patents are all based on the principle of nourishing qi and nourishing yin. , even if it takes into account nourishing dryness and heat, its effect is minimal; and there is no Chinese patent medicine to intervene in Sjögren's syndrome on the market

Images